Previous 10 | Next 10 |
home / stock / mrvl / mrvl articles
Marvell Technology Inc (NASDAQ:MRVL) shares are trading lower by 1.84% to $66.95 during Friday’s session and 10.4% over the trailing week. Se...
Marvell Technology, Inc. (NASDAQ:MRVL) shares are trading lower Thursday amid a sell-off in the semiconductor sector. The Details: The Nasdaq...
Chip stocks led by Nvidia Corp (NASDAQ:NVDA) and Advanced Micro Devices, Inc (NASDAQ:AMD) are trading lower Wednesday as the U.S. intensified semic...
Marvell Tech (NASDAQ:MRVL) has outperformed the market over the past 5 years by 9.97% on an annualized basis producing an average annual return of ...
Although U.S. stocks closed mixed on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence ...
Piper Sandler analyst Brent Bracelin said the breadth of enterprise adoption of generative AI has surprised him again. Nearly half of enterprises (...
In a bid to secure a stable supply of high-end chips amid U.S.-China tensions, TikTok-parent ByteDance is reportedly collaborating with U.S. chip d...
One stock that might be an intriguing choice for investors right now is Marvell Technology, Inc. (NASDAQ: MRVL). This is because this security in t...
Steve Cohen's Point72 Asset Management is set to launch a new hedge fund with a focus on artificial intelligence, aiming to raise approximatel...
News, Short Squeeze, Breakout and More Instantly...
Marvell Technology Inc. Company Name:
MRVL Stock Symbol:
NASDAQ Market:
Marvell Technology Inc. Website:
Calgary, Alberta--(Newsfile Corp. - July 19, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the " Company " or " Marvel "), is pleased to report that, further to its press releases of May 16, 2024 and June 21, 2024, it has ...
2024-07-15 18:00:00 ET Broadcom (NASDAQ: AVGO) and Marvell Technology (NASDAQ: MRVL) usually don't attract as much attention as higher-growth chipmakers like Nvidia (NASDAQ: NVDA) . But like Nvidia, both diversified chip specialists are benefiting from the rapid ...
Calgary, Alberta--(Newsfile Corp. - July 9, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to highlight the recently published paper "Neuronal A2A receptor exacerbate...